Medicare Enrolled

Dr. Steven Fein, M.D.

Hematology & Oncology · Miami, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
8255 S DIXIE HWY, Miami, FL 33143
3054581384
Registered in NPPES since 2005
NPI: 1437146552 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fein

Dr. Steven Fein is a hematology & oncology specialist in Miami, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Fein performed 52,097 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Fein received a total of $1,190,321 from 54 pharmaceutical and/or device companies across 1441 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 16% volume in FL $1,190,321 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
52,097
Medicare services
Top 16% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Feraheme)
An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis.
50,490 $0 $20
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
437 $82 $700
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
353 $98 $875
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
176 $139 $1,687
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
175 $105 $1,160
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
115 $59 $315
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
109 $54 $690
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
107 $17 $207
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
103 $48 $624
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
32 $101 $207
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
97.3% high complexity
0.0% medium
2.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,190,321
Total received (2018-2024)
Avg $170,046/year across 7 years
Top 1% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
1,441
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$90,607
2023
$93,599
2022
$169,479
2021
$288,140
2020
$147,586
2019
$156,157
2018
$244,752

Payments by company (2024)

Pharmacosmos Therapeutics Inc.
$48,951
Agios Pharmaceuticals, Inc.
$35,766
Novartis Pharmaceuticals Corporation
$2,700
Amgen Inc.
$1,932
Janssen Pharmaceuticals, Inc
$1,000
SOBI, INC
$123
Bayer Healthcare Pharmaceuticals Inc.
$65
American Regent
$50
RECORDATI_RARE_DISEASES_INC.
$21
Top 3 companies account for 96.5% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$194,865
Pharmacosmos Therapeutics Inc.
$142,261
Daiichi Sankyo Inc.
$131,547
PFIZER INC.
$108,300
Dova Pharmaceuticals
$106,727
Incyte Corporation
$82,510
Sobi, Inc
$61,824
Agios Pharmaceuticals, Inc.
$59,627
GENZYME CORPORATION
$49,920
Novartis Pharmaceuticals Corporation
$38,616
Janssen Pharmaceuticals, Inc
$38,405
BeiGene USA, Inc.
$27,506
SOBI, INC
$24,424
Celgene Corporation
$21,421
BTG International, Inc.
$16,859
Bayer HealthCare Pharmaceuticals Inc.
$15,272
Rigel Pharmaceuticals, Inc.
$7,828
Seattle Genetics, Inc.
$7,607
Pharmacyclics LLC, An AbbVie Company
$7,241
BTG INTERNATIONAL, INC.
$6,300
E.R. Squibb & Sons, L.L.C.
$6,026
PORTOLA PHARMACEUTICALS, INC.
$5,653
Kite Pharma, Inc.
$5,491
NOVARTIS PHARMACEUTICALS CORPORATION
$4,128
Gilead Sciences, Inc.
$3,598
Octapharma USA, Inc.
$3,121
Takeda Pharmaceuticals U.S.A., Inc.
$2,823
Teva Pharmaceuticals USA, Inc.
$2,330
BIOVERATIV THERAPEUTICS INC.
$2,012
Janssen Research & Development, LLC
$1,502
Epizyme, Inc.,
$1,330
Servier Pharmaceuticals LLC
$775
SERVIER PHARMACEUTICALS LLC
$674
Janssen Scientific Affairs, LLC
$230
Astellas Pharma US Inc
$176
SANOFI-AVENTIS U.S. LLC
$157
AstraZeneca Pharmaceuticals LP
$140
Alexion Pharmaceuticals, Inc.
$127
Merck Sharp & Dohme Corporation
$124
Ipsen Biopharmaceuticals, Inc
$121
Genentech USA, Inc.
$120
Stemline Therapeutics Inc.
$118
EMD Serono, Inc.
$81
Bayer Healthcare Pharmaceuticals Inc.
$79
Terumo BCT, Inc.
$63
Merck Sharp & Dohme LLC
$56
American Regent
$50
RefleXion Medical, Inc.
$43
Janssen Biotech, Inc.
$29
RECORDATI_RARE_DISEASES_INC.
$21
G1 Therapeutics, Inc.
$19
Seagen Inc.
$18
AbbVie Inc.
$15
Taiho Oncology, Inc.
$13
Top 3 companies account for 39.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ANDEXXA · ASPARLAS · ATTP DISEASE · Aliqopa · BAVENCIO · BESPONSA · BEVYXXA · BRUKINSA · Blincyto · CABLIVI · CALQUENCE · CHANTIX · COLD AGGLUTININ DISEASE · COSELA · DARZALEX · DISEASE STATE · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELZONRIS · ENHERTU · ENJAYMO · ERLEADA · GAZYVA · IMBRUVICA · IMFINZI · INJECTAFER · INREBIC · Imbruvica · Inrebic · JAKAFI · JEVTANA · KEYTRUDA · Kadcyla · Kyprolis · LONSURF · MONOFERRIC · MYLOTARG · Mirena · Monoferric · NINLARO · NUWIQ · Neulasta · Nplate · ONCASPAR · OPDIVO · Onivyde · PADCEV · PROMACTA · PYRUKYND · Perjeta · REFLEXION MEDICAL RADIOTHERAPY SYSTEM · RYDAPT · Revlimid · SARCLISA · SOLIRIS · SPRYCEL · SYLVANT · Stivarga · TASIGNA · TAZVERIK · Tavalisse · Tibsovo · Truxima · VENCLEXTA · VORAXAZE · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XARELTO · XOSPATA · Xofigo · Yescarta · Zydelig
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Miami?
Compare hematology & oncology specialists in the Miami area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
154
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
SOUTH MIAMI HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Fein is a mixed practice specialist, with above-average Medicare volume (top 16% in FL), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Fein experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Fein performed 50,490 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Fein receive payments from pharmaceutical companies?
Yes. Dr. Fein received a total of $1,190,321 from 54 companies across 1,441 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fein's costs compare to other hematology & oncology specialists in Miami?
Dr. Fein's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →